BUPRENORPHINE-NALOXONE 4-1 MG SL FILM

Buprenorphine and Naloxone
$2.2824per EA
DEA Schedule CIII

Strength

4; 1 mg/1; mg/1

Manufacturer

Alvogen Inc.

NDC

47781035603

Classification

Generic

Dosage Form

FILM

Route

BUCCAL; SUBLINGUAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205954

On Market Since

2/11/2019

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

+2.7%

3M

-3.6%

6M

-34.0%

1Y

-34.8%

3Y

-40.0%

5Y

-51.8%

All

-58.7%